DepoMed, Inc. (DEPO) Tops Q1 EPS by 20c
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Price: $7.30 --0%
Financial Fact:
Total selling, general and administrative expense: 51.57M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Total selling, general and administrative expense: 51.57M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
DepoMed, Inc. (NASDAQ: DEPO) reported Q1 EPS of $0.30, $0.20 better than the analyst estimate of $0.10. Revenue for the quarter came in at $76.54 million versus the consensus estimate of $53.57 million.
For earnings history and earnings-related data on DepoMed, Inc. (DEPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Marpai, Inc. (MRAI) Misses Q2 EPS by 18c
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
